CHOP Researchers Develop First Effective Preclinical Models for Most Common Genetic Cause of Leigh Syndrome
Published on in CHOP News
Translational findings in new models of SURF1 mitochondrial disease also suggest that two drugs, already FDA-approved for other conditions, may prevent neurological decompensation in Leigh syndrome patients.